Veröffentlichungen - Gesundheitsökomomische Evaluation

Bock J, Brettschneider C, Seidl H, Bowles D, Holle R, Greiner W, König H (2015)
Ermittlung standardisierter Bewertungssätze aus gesellschaftlicher Perspektive für die gesundheitsökonomische Evaluation
Gesundheitswesen, 77(1):53-61.

Brettschneider C, Luck T, Fleischer S, Roling G, Beutner K, Luppa M, Behrens J, Riedel-Heller SG, König HH (2015)
Cost-utility analysis of a preventive home visit program for older adults in Germany. BMC Health Serv Res, 15:141.

Brettschneider C, Djadran H, Härter M, Löwe B, Riedel-Heller SG, König HH (2015)
Cost-utility analyses of cognitive-behavioural therapy of depression: a systematic review. Psychother Psychosom, 84:6-21.

Egger N, Konnopka A, Beutel ME, Herpertz S, Hiller W, Hoyer J, Salzer S, Stangier U, Strauss B, Willutzki U, Wiltink J, Leichsenring F, Leibing E, König HH (2015)
Short-term cost-effectiveness of psychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder: Results from the SOPHO-NET trial. J Affect Disord, 180:21-28.

Eisele M, Kaduszkiewicz H, König H, Lange C, Wiese B, Prokein J, Weyerer S, Werle J, Riedel-Heller S, Luppa M, Heser K, Koppara A, Mösch E, Weeg D, Fuchs A, Pentzek M, Maier W, Scherer M, Hajek A (2015)
Determinants of health-related quality of life in older primary care patients: results of the longitudinal observational AgeCoDe Study
British Journal of General Practice; 65(640): e716-23.

Grupp H, König H, Konnopka A (2015)
Kostensätze zur monetären Bewertung von Versorgungsleistungen bei psychischen Erkrankungen. Gesundheitswesen

König H, Grochtdreis T, Brettschneider C (2015)
Gesundheitsökonomische Evaluationen im Rahmen von psychenet. Psychiat. Prax.; 42 (1):70-74.

König HH, Lehnert T, Brenner H, Schöttker B, Quinzler R, Haefeli WE, Matschinger H, Heider D (2015). Health service use and costs associated with excess weight in older adults in Germany. Age Ageing [Epub 2015 Mar 31].

Ramirez A, Wolfsgruber S, Lange C, Kaduszkiewicz H, Weyerer S, Werle J, Pentzek M, Fuchs A, Riedel-Heller SG, Luck T, Mösch E, Bickel H, Wiese B, Prokein J, König HH Brettschneider C, Breteler MM, Maier W, Jessen F, Scherer M; AgeCoDe Study Group (2015). Elevated HbA1c is associated with increased risk of incident dementia in primary care patients. J Alzheimers Dis 44 (4):1203-12.

Sandmann A, Amling M, Barvencik F, König H, Bleibler F (2015)
Economic evaluation of vitamin D and calcium food fortification for fracture prevention in Germany. Public Health Nutr.; 1-10.

Sonntag M, König H, Konnopka A (2015)
The responsiveness of the EQ-5D and time trade-off scores in schizophrenia, affective disorders, and alcohol addiction. Health and Quality of Life Outcomes; 13:114.

Stein J, Luppa M, Kaduszkiewicz H, Eisele M, Weyerer S, Werle J, Bickel H, Mösch E, Wiese B, Prokein J, Pentzek M, Fuchs A, König HH, Brettschneider C, Heser K, Wagner M, Riedel-Heller SG, Scherer M, Maier W (2015). Is the Short Form of the Mini-Mental State Examination (MMSE) a Better Screening Instrument for Dementia in Older Primary Care Patients Than the Original MMSE? Results of the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe). Psychol Assess [Epub 2015 Mar 30].

Stein J, Luppa M, König HH, Riedel-Heller SG (2015). The German version of the Camberwell Assessment of Need for the Elderly (CANE): evaluation of content validity and adaptation to the German-speaking context. Int Psychogeriatr 15:1-8. 

Stuhldreher N, Wild B, König HH, Konnopka A, Zipfel S, Herzog W (2015). Determinants of direct and indirect costs in anorexia nervosa. Int J Eat Disord 48(1):139-146.

Achelrod D, Stargardt T. Cost-Utility Analysis Comparing Heavy-Weight and Light-Weight Mesh in Laparoscopic Surgery for Unilateral Inguinal Hernias. Applied Health Economics and Health Policy. 2014; 12(2):151-163.

Augustin M, Brocatti LK, Rustenbach SJ, Schäfer I, Herberger K. Cost-of-illness of leg ulcers in the community. Int Wound J. 2014; Jun 11(3):283-92.

Bock JO, Luppa M, Brettschneider C, Riedel-Heller S, Bickel H, Fuchs A, Gensichen J, Maier W, Mergenthal K, Schäfer I, Schön G, Weyerer S, Wiese B, van den Bussche H, Scherer M, König HH. Impact of depression on health care utilization and costs among multimorbid patients – Results from the MultiCare Cohort Study. 2014; PLoS ONE 9(3):e91973.

Brettschneider C, Riedel-Heller SG, König HH (2014). A Systematic Review if Economic Evaluations of Treatments for Borderline Personality Disorder. PLoS ONE 9(9).

Fischer KE, Rogowski WH. Funding Decisions for Newborn Screening: A Comparative Review of 22 Decision Processes in Europe. Int J of Environmental Research and Public Health. 2014;11(5):5403–5430.

Frey S, Linder R, Juckel G, Stargardt T.  Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data. Eur J Health Econ.  2014; 15(2):133–142.

Gensichen J, Hiller TS, Breitbart J, Teismann T, Brettschneider C, Schumacher U, Piwtorak A, König HH, Hoyer H, Schneider N, Schelle M, Blank W, Thiel P, Wensing M, Margraf J. Evaluation of a practice team-supported exposure training for patients with panic disorder with or without agoraphobia in primary care - study protocol of a cluster randomised controlled superiority trial. Trials. 2014; 15(1):112.

Grupp H, König HH, Konnopka A (2014). Cost Measurement of Mental Disorders in Germany. J Ment Health Policy 17(1):3-8.

Hansen H, Schäfer I, Schön G, Riedel-Heller S, Gensichen J, Weyerer S, Petersen JJ, König HH, Bickel H, Fuchs A, Höfels S, Wiese B, Wegscheider K, van den Bussche H, Scherer M. Agreement between self-reported and general practitioner-reported chronic conditions among multimorbid patients in primary care – results of the MultiCare Cohort Study. BMC Fam Pract. 2014; 15(1):39.

Karow A, Bock T, Daubmann A, Meigel-Schleiff C, Lange B, Lange M, Ohm G, Bus-sopulos A, Frieling M, Golks D, Kerstan A, König HH, Nika L, Lange M, Ruppelt F, Schödlbauer M, Schöttle D, Sauerbier AL, Rietschel L, Wegscheider K, Wiedemann K, Schimmelmann BG, Naber D, Lambert M. Integrierte Versorgung von Patienten mit psychotischen Erkrankungen nach dem Hamburger Modell: Teil 2. Psychiatr Prax. 2014; 41(5):266-273.

König HH, Leicht H, Brettschneider C, Bachmann C, Bickel H, Fuchs A, Jessen F, Köhler M, Luppa M, Mösch E, Pentzek M, Werle J, Weyerer S, Wiese B, Scherer M, Maier W, Rieder-Heller SG for the AgeCoDe study group. The costs of dementia from the societal perspective: Is care provided in the community really cheaper than nursing home care? J Am Med Dir Assoc. 2014; 15(2):117-126.

Konnopka A, Stuhldreher N, Klingberg S, Wittorf A, Bechdolf A, Müller BW, Sartory G, Wagner M, Wiedemann G, Wölwer W, Heinrich S, König HH. Determinanten direkter Kosten bei persistierender Positivsymptomatik psychotischer Erkrankungen. Psychiatr Prax. 2014; 41(4):215-220.

Lambert M, Bock T, Daubmann A, Meigel-Schleiff C, Lange B, Lange M, Ohm G, Bussopulos A, Frieling M, Golks D, Kerstan A, König HH, Nika L, Ruppelt F, Schödlbauer M, Schöttle D, Sauerbier AL, Rietschel L, Wegscheider K, Wiedemann K, Schimmelmann BG, Naber D, Karow A. Integrierte Versorgung von Patienten mit psychotischen Erkrankungen nach dem Hamburger Modell: Teil 1. Psychiatr Prax. 2014; 41(5):257-265.

Langenbruch A, Radtke M, Franzke N, Ring J, Foelster-Holst R, Augustin M: Quality of health care of atopic eczema in Germany: results of the national health care study AtopicHealth. J Eur Acad Dermatol Venereol. 2014; Jun;28(6):719-26.

Lehnert T, Stuhldreher N, Streltchenia P, Riedel-Heller SG, König HH. Sick leave days and costs associated with overweight and obesity in Germany. J Occup Environ Med. 2014; 56(1):20-27.

Lindlbauer I, Schreyögg J (2014). The realtionship between hospital specialization and hospital efficiency: di different measures of specialization lead to different results? Health Care Manag Sci 17(4):365-378.

Löbner M, Luppa M, Konnopka A, Meisel HJ, Günther L, Meixensberger J, Stengler K, Angermeyer MC, König HH, Riedel-Heller SG. Inpatient or outpatient rehabilitation after herniated disc surgery? – setting-specific preferences, participation and outcome of rehabilitation. 2014; Mar 5;9(3):e89200.

Nützel A, Dahlhaus A, Fuchs A, Gensichen J, König HH, Riedel-Heller S, Maier W, Schäfer I, Schön G, Weyerer S, Wiese B, Scherer M, van den Bussche H, Bickel H. Self-rated health in multimorbid older general practice patients: a cross-sectional study in Germany. BMC Fam Pract. 2014; 15:1.

Schulz S, Brenk-Franz K, Kratz A, Petersen JJ, Riedel-Heller SG, Schäfer I, Weyerer S, Wiese B, Fuchs A, Maier W, Bickel H, König HH, Scherer M, Bussche H van den, Gensichen J for the MultiCare study-group (2014). Self-efficacy in multimorbid elderly patients with osteoarthritis in primary care – influence on pain related disability. Clin Rheumatol [Epub 2014 Sep 6].

Stargardt T, Schreyögg J, Kondofersky I. Measuring the Relationship between Costs and Outcomes: the Example of Acute Myocardial Infarction in German Hospitals, Health Economics. 2014; 23(6):653-69.

Stein J, Luppa M, Ruzanska U, Sikorski C, König HH, Riedel-Heller SG (2014). Measuring negative attitudes towards overweight and obesity in the German population - psychometric properties and reference values for the German short version of the Fat Phobia Scale (FPS). PLoS One 9(12):e114641.

Stuhldreher N, Leibing E, Leichsenring F, Beutel ME, Herpertz S, Hoyer J, Konnopka A, Salzer S, Strauss B, Wiltink J, König HH (2014). The costs of social anxiety disorder: The role of symptom severity and comorbidities. J Affect Disord 165:87-94.

Watzke B, Heddaeus D, Steinmann M, König HH, Wegscheider K, Schulz H, Härter M (2014). Effectiveness and cost-effectiveness of a guideline-based stepped care model for patients with depression: study protocol of a cluster-randomized controlled trial in routine care. BMC psychiatry 14:230.

Wild B, Heider D, Maatouk I, Slaets J, König HH, Niehoff D, Saum KU, Brenner H, Söllner W, Herzog W (2014). Significance and costs of complex bio-psycho-social health care needs in elderly people – results of a population-based study. Psychosom Med 76(7):497-502.

Blankart R, Koch T, Linder R, Verheyen F, Schreyögg J, Stargardt T. Cost of illness and economic burden of chronic lymphocytic leukemia, Orphanet Journal of Rare Diseases. 2013; 8(1):32.

Bleibler F, Konnopka A, Benzinger P, Rapp K, König HH. The health burden and costs of incident fractures attributable to osteoporosis from 2010 to 2050 in Germany – A demographic simulation model. Osteoporos Int. 2013; 24(3):835-847.

Blome C, Beikert FC, Rustenbach SJ, Augustin M.  Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilities. Arch Dermatol Res. 2013; 305:197–204.

Brettschneider C, König HH, Herzog W, Kaufmann C, Schaefert R, Konnopka A. Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with somatoform disorders. Health Qual Life Outcomes. 2013; 11:3.

Bussche H van den, Schäfer I, Wiese B, Dahlhaus A, Fuchs A, Gensichen J, Höfels S, Hansen H, Leicht H, Koller D, Luppa M, Nützel A, Werle J, Scherer M, Wegscheider K, Glaeske G, Schön G (2013). A comparative study demonstrated that prevalence figures on multimorbidity require cautious interpretation when drawn from a single database. J Clin Epidemiol. 2013; 66(2):209-217.

Diepgen TL, Purwins S, Posthumus J, Kuessner D, John SM, Augustin M. Cost-of-illness Analysis of Patients with Chronic Hand Eczema in Routine Care in Germany: Focus on the Impact of Occupational Disease. Acta Derm Venereol. 2013; 93.

Gensichen J, Petersen JJ, Von Korff M, Heider D, Baron S, König J, Freytag A, Krauth C, Gerlach FM, König H-H. Cost-effectiveness of depression case management in small practices. Br J Psychiatry. 2013; 202: 441–446.

Haas L, Stargardt T, Schreyögg J, Schlösser R, Danzer G, Klapp BF. The trade-off between costs and quality of care in the treatment of psychosomatic patients with somatoform pain disorder. Applied Health Economics and Health Policy. 2013; 11: 359-368.

Heinrich S, Rapp K, Stuhldreher N, Rissmann U, Becker C, König HH. Cost-effectiveness of a multifactorial fall prevention program in nursing homes. Osteoporos Int. 2013; 24(4): 1215-1223.

König HH. Gesundheitsökonomische Evaluation. In: Roeder N, Hensen P (Hrsg.). Gesundheitsökonomie, Gesundheitssystem und öffentliche Gesundheitspflege. Kurzlehrbuch für Studierende der Medizin. Köln: Deutscher Ärzteverlag, 2. aktualisierte Auflage. 2013; 238-257.

Lehnert T, Sonntag D, Konnopka A, Riedel-Heller S, König H-H. Economic costs of overweight and obesity. Best Pract Res Clin Endocrinol Metab. 2013; 27:105–115.

Luppa M, König HH, Heider D, Leicht H, Motzek T, Schomerus G, Riedel-Heller SG. Direct costs associated with depressive symptoms in old age: a 4.5-year pro-spective study. Int Psychogeriatr. 2013; 25(2):292-302.

Sonntag M, König HH, Konnopka A. The estimation of utility weights in cost-utility analysis for mental disorders: A systematic review. Pharmacoeconomics. 2013; 31(12):1131-1154.

Sonntag M, Konnopka A, Leichsenring F, Salzer S, Beutel ME, Herpertz S, Hiller W, Hoyer J, Joraschky P, Nolting B, Pöhlmann K, Stangier U, Strauss B, Willutzki U, Wiltink J, Leibing E, König HH. Reliability, validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with social phobia. Health Qual Life Outcomes. 2013; 11:215.

Ständer S, Augustin M, Reich A, Blome C, Ebata T, Phan NQ, Szepietowski JC.  Pruritus Assessment in Clinical Trials: Consensus Recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials. Acta Dermato-Venereologica. 2013.

Thaçi D, Weisenseel P, Philipp S, Rosenbach T, Rotterdam S, Augustin M, Neureither M, Reich K. Efficacy and safety of fumaric acid esters in patients with psoriasis on medication for comorbid conditions - a retrospective evaluation (FACTS). J Dtsch Dermatol Ges. 2013; 11:429–435.

Then FS, Luppa M, Schroeter ML, König HH, Angermeyer MC, Riedel-Heller SG. Enriched Environment at Work and the Incidence of Dementia: Results of the Leipzig Longitudinal Study of the Aged (LEILA 75+). 2013; Jul 26;8(7):e70906.

Augustin M, Blome C, Zschocke I, Schaefer I, Koenig S, Rustenbach SJ, Herberger K. Benefit Evaluation in the Therapy of Chronic Wounds from the Patients' Perspective-Development and Validation of a New Method. Wound Repair Regen. 2012; 20 (1): 8-14.

Augustin M, Glaeske G, Schaefer I, Rustenbach SJ, Hoer A, Radtke MA.  Versorgungsprozesse der Psoriasis in Deutschland - Langzeitanalyse von Sekundärdaten der gesetzlichen Krankenversicherung. J Dtsch Dermatol Ges. 2012; 10 (9): 648-655.

Bäumler M, Stargardt T, Schreyögg J, Busse R. Cost-effectiveness of drug-eluting stents in AMI patients in Germany. Applied Health Economics and Health Policy. 2012; 10(4): 235-248.

Feuerhahn J, Blome C, Radtke MA, Augustin M.  Validation of the Patient Benefit Index for the Assessment of PatientRelevant Benefit in the Treatment of Psoriasis. Arch Dermatol Res. 2012; 304(6): 433-441.

Frey S, Stargardt T. Performance of compliance and persistence measures in predicting clinical and economic outcomes using administrative data from german sickness funds. Pharmacotherapy. 2012; 32(10): 880–889.

Gutknecht M, Blome C, Augustin M. Patientenrelevanter Nutzen: Subjektivität objektiv gemessen. PM Report. 2012; 8: 36-38.

Haas L, Stargardt T, Schreyögg J. Cost-effectiveness of open versus laparoscopic appendectomy: a multilevel approach with propensity score matching. European Journal of Health Economics. 2012; 13(5): 549-560.

Haas L, Stargardt T, Schreyögg J, Schlössel R, Danzer G, Klapp BF. Introduction of DRG-based reimbursement in inpatient psychosomatics- An examination of cost homogeneity and cost predictors in the treatment of patients with eating disorders. Journal of Pyschosomatic Research. 2012; 73(5): 383-390.

Haas L, Stargardt T, Schreyögg J, Schlösser R, Danzer G, Klapp BF. Inpatient costs and predictors of cost in the psychosomatic treatment of anorexia nervosa. International Journal of Eating Disorders. 2012; 45(2): 214-221.

Heinrich S, Weigelt I, Rapp K, Becker C, Rissmann U, König HH. Sturz- und Frakturprävention auf der Grundlage des Nationalen Expertenstandards Sturzprophylaxe: Umsetzung und Kosten im Versorgungsalltag im Setting Pflegeheim. Zeitschrift für Gerontologie und Geriatrie. 2012; 45(2):128-137.

Heimeshoff M, Hollmeyer H, Schreyögg J, Tiemann O, Staab D. Cost of Illness of Cystic fibrosis in Germany. Pharmacoeconomics. 2012; 30(9): 763-777.

Herberger K, Debus ES, Larena-Avellaneda A, Blome C, Augustin M.  Effectiveness, Tolerability, and Safety of Electrical Stimulation of Wounds With an Electrical Stimulation Device: Results of a Retrospective Register Study. Wounds. 2012; 24 (4): 76-84.

Heyer K, Augustin M, Krensel M, Spehr C, Pogatzki-Zahn E, Osterbrink J. Gesundheitsökonomische Evaluation der postoperativen Schmerztherapie in der Routineversorgung - Am Beispiel von sechs kommunaken Krankenhäusern. Gefäßchirurgie. 2012; 17: 757-762.

Karow A, Reimer J, König HH, Heider D, Bock T, Huber C, Schöttle D, Meister K, Rietschel L, Ohm G, Schulz H, Naber D, Schimmelmann BG, Lambert M. Cost-effectiveness of 12-month therapeutic Assertive Community Treatment as part of Integrated Care vs. Standard Care in patients with schizophrenia treated with Quet-iapine IR (ACCESS Trial). Journal of Clincal. 2012; Psychiatry 73(3): 402-408. 

Konnopka A, Schaefert R, Heinrich S, Kaufmann C, Luppa M, Herzog W, König HH. Economics of Medically Unexplained Symptoms: A Systematic Review of the Literature. Psychother Psychosom. 2012; 81(5):265-275.

Lehnert T, Sonntag D, Konnopka A, Riedel-Heller SG, König HH. The longterm cost-effectiveness of obesity prevention interventions: systematic literature review. Obesity Reviews. 2012; 13(6): 557-553.

Leicht H, König HH. Krankheitskosten bei Demenz aus gesellschaftlicher Perspektive: Eine Übersicht. Bundesgesundheitsblatt. 2012; 55:677-684.

Leidl R, Reitmeir P, König HH, Stark R.  The performance of a value set for the EQ-5D based on experienced health states in patients with inflammatory bowel disease. Value Health. 2012; 15(1): 151-157.

Luppa M, Sikorski C, Motzek T, Konnopka A, König HH, Riedel-Heller SG. Health Service Utilization and Costs of Depressive Symptoms in Late Life – A Systematic Review. Curr Pharm Des. 2012; 18(36):5936-5957. 

Mueller C, Augustin M. Willingness-to-Pay and Patient Defined Benefits in the Treatment of Hyperhidrosis - Results from the First German Health Services Research Study in Hyperhidrosis. Br J Dermatol. 2012; 168 (2): 448-50.

Phan NQ, Blome C, Fritz F, Gerss J, Reich A, Ebata T, Augustin M, Szepietowski JC, Staender S.  Assessment of Pruritus Intensity: Prospective Study on Validity and Reliability of the Visual Analogue Scale, Numerical Rating Scale and Verbal Rating Scale in 471 Patients with Chronic Pruritus. Acta Derm Venereol. 2012; 92 (5): 502-507.

Reich A, Heisig M, Phan NQ, Taneda K, Takamori K, Takeuchi S, Furue M, Blome C, Augustin M, Staender S, Szepietowski JC. Visual Analogue Scale: Evaluation of the Instrument for the Assessment of Pruritus. Acta Derm Venerol. 2012; 92 (5): 497-501.

Roll K. The influence of regional health care structures on delay in diagnosis of rare diseases: The case of Marfan Syndrome. Health Policy. 2012; 105(2-3): 119-127.

Sarlon E, Heider D, Millier A, Azorin JM, König HH, Hansen K, Angermeyer MC, Aballéa S, Toumi M. A prospective study of health care resource utilisation and selected costs of schizophrenia in France. BMC Health Serv Res. 2012; 12:269

Schreyögg J, Stargardt T. Gesundheitsökonomische Evaluation auf Grundlage von GKV Routinedaten. Bundesgesundheitsblatt. 2012; 55:668–676.

Stargardt T, Edel MA, Ebert A, Busse R, Juckel G, Gericke CA: Effectiveness and cost of atypical versus typical antipsychotic treatment in a nationwide cohort of schizophrenic patients in Germany. Journal of Clinical Psychopharmacology. 2012; 32(5): 602-607.

Stargardt T, Schreyögg J. A framework to evaluate effects of small are variations in health care infrastructure on diagnostics and patient outcomes of orphan diseases. Health Policy. 2012; 105(2-3): 110-118.

Stengler K, Zieger M, Luppa M, Meisel HJ, Günther L, Meixensberger J, Toussaint R, Angermeyer MC, König HH, Riedel-Heller SG . The Impact of Psychiatric Comorbidity on Quality of Life in Patients Undergoing Herniated Disc Surgery. J Neurol Surg A Cent Eur Neurosurg. 2012; 73(1):29-37.

Stuhldreher N, Konnopka A, Wild B, Herzog W, Zipfel S, Löwe B, König HH. Cost-of-illness studies and cost-effectiveness analyses in eating disorders: A systematic review. International Journal of Eating Disorders. 2012; 45(4): 476-491.

Westerhout KY, Verheggen BG, Schreder CH, Augustin M.  Cost Effectiveness Analysis of Immunotherapy in Patients with Grass Pollen Allergic Rhinoconjunctivitis in Germany. J Med Econ. 2012; 15 (5): 906-917.

Augustin M, Kuessner D, Purwins S, Hieke K, Posthumus J, Diepgen TL. Cost-of-Illness of Patients with Chronic Hand Eczema in Routine Care: Results from a Multi-Centre Study in Germany. Br J Dermatol. 2011; 165 (4): 845-851.

Augustin M, Chapnik J, Gupta S, Buesch K, Radtke M. Psoriasis verursacht hohe Kosten, mindert die Produktivität am Arbeitsplatz und verringert die Lebensqualität. Akt Dermatol. 2011; 37 (10): 353-359.

Blome C, Augustin M, Behechtnejad J, Rustenbach SJ.  Dimensions of patient needs in dermatology: subscales of the patient benefit index. Archieves of dermatological Research. 2011; 303(1): 11-17.

Brettschneider C, Lühmann D, Raspe H. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA). Health Technology Assessment. 2011; 7(1).

Corrieri S, Heider D, Riedel-Heller SG, Matschinger H, König HH.  Cost-effectiveness of fall prevention programs based on home visits in seniors aged over 65 years - a systematic review. International Psychogeriatric Association. 2011; 12, 1-13.

Dulon M, Wendeler D, Nienhaus A.  Sind randomisierte kontrollierte Studien in der Altenpflege möglich? - Erfahrungen aus der KRISTA-Studie. Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie. 2011; 61(3): 84.

Franzke N, Augustin M. Dermatologische Versorgungsforschung in Deutschland. Der Hautarzt. 2011; 62(3): 170-177.

Franzke N, Schaefer I, Jost K, Blome C, Rustenbach SJ, Reich K, Reusch M, Maurer M, Augustin M.  A New Instrument for the Assessment of Patient-Defined Benefit in the Treatment of Allergic Rhinitis. Allergy. 2011; 66 (5): 665-670.

Giersiepen K, Lelgemann M, Stuhldreher N, Ronfani L, Husby S, Koletzko S, Korponay-Szabó.  Accuracy of Diagnostic Antibody-Tests for Coeliac Disease in Children: Summary from an Evidence Report. Journal of Pediatric Gastroenterology and Nutrition, accepted.

Haas L.  Präferenzmessung von Patienten in medizinischen Versorgungszentren (MVZ) - eine Gegenüberstellung der Behandlungsqualität von MVZ und niedergelassenen Haus- und Fachärzten. Das Gesundheitswesen, accepted.

Heinrich S, Rapp K, Rissmann U, Becker C, König HH.  Service Use and Costs of Incident Femoral Fractures in Nursing Home Residents in Germany: The Bavarian Fall and Fracture Prevention Project (BF2P2).  Journal of the American Medical Directors Association. 2011; 12(6), 459-466.

Herberger K, Franzke N, Blome C, Kirsten N, Augustin M.  Efficacy, Tolerability and Patient Benefit of UltrasoundAssisted Wound Treatment versus Surgical Debridement: A Randomized Clinical Study. Dermatology. 2011 ; 222 (3): 244-249.

Herberger K, Rustenbach SJ, Haartje O, Blome C, Franzke N, Schaefer I, Radtke M, Augustin M.  Quality of Life and Satisfaction of Patients with Leg Ulcers - Results of a Community-Based Study. Vasa. 2011 ; 40 (2): 131-138.

Herberger K, Rustenbach SJ, Grams L, Münter KC, Schäfer E, Augustin M.  Quality-of-care for leg ulcers in the metropolitan area of Hamburg - A community-based Study. Journal of the European Academy of Dermatology and Venereology, in press.

Hollmeyer H, Schreyögg J, Wahn U, Staab D.  Staff costs of outpatient care of patients with cystic fibrosis. Health Economics Review.  2011;  1:10.

Köhler M, Kliegel M, Wiese B, Bickel H, Kaduszkiewicz H, Bussche H van den, Eiffla-ender-Gorfer S, Eisele M, Fuchs A, König HH, Leicht H, Luck T, Maier W, Mösch E, Riedel-Heller S, Tebarth F, Wagner M, Weyerer S, Zimmermann T, Pentzek M. Malperformance in verbal fluency and delayed recall as cognitive risk factors for impairment in instrumental activities of daily living. Dement Geriatr Cogn Disord. 2011; 31(1):81-88. 

Konnopka A, Bödemann M, König HH. Health burden and costs of obesity and overweight in Germany. European Journal of Health Economics.  2011; 12(4): 345-352.

Konnopka A, Heinrich S, Zieger M, Luppa M, Riedel-Heller SG, Meisel HJ, Günther L, Meixensberger J, König HH.  Effects of psychiatric comorbidity on costs in patients undergoing disc surgery: a cross-sectional study.  Spine Journal. 2011; 11(7): 601-609.

Krenzer S, Radtke M, Schmitt-Rau K, Augustin M.  Characterization of Patient-Reported Outcomes (PRO) in moderate to severe psoriasis. Dermatology. 2011; 223 (1): 80-86.

Radtke MA, Schäfer I, Blome C, Augustin M. Patient Benefit Index (PBI) in the treatment of psoriasis - Results of the National Care Study "PsoHealth". Journal of the European Academy of Dermatology and Venereology, 2011; in press.

Schwegler J, Schwarz J, Eulenburg C, Blome C, Ihnen M, Mahner S, Jaenicke F, Augustin M, Woelber L.  Health-Related Quality of Life and Patient-Defined Benefit of Clobetasol 0.05% in Women with Chronic Lichen Sclerosus of the Vulva. Dermatology. 2011; 223 (2): 152-160.

Sevilla-Dedieu C, Kovess-Masféty V, Gilbert F, Vilagut G, König HH, Bruffaerts R, Haro JM, Alonso J.  Mental Health Care and Out-of-Pocket Expenditures in Europe: Results from the ESEMeD Project. The Journal of Mental Health Policy and Economics. 2011; 14(2): 95-105.

Augustin M, Blome C, Rustenbach SJ, Reusch M, Radtke M.  Das Hautkrebsscreening als Regelleistung der gesetzlichen Krankenkassen: Erste Daten zu den Auswirkungen auf die dermatologische Versorgung [Routine Skin Cancer Screening in Germany: First Data on the Impact on Health Care in Dermatology]. J Dtsch Dermatol Ges 2010.

Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schaefer I. Epidemiology and Comorbidity of Psoriasis in Children. Br J Dermatol. 2010; 162 (3): 633-636.

Augustin M, Herberger K, Rustenbach SJ, Schäfer I, Zschocke I, Blome C.  Quality of life evaluation in wounds: validation of the Freiburg Life Quality Assessment-wound module, a disease-specific instrument.  International Wound Journal. 2010; 7(6): 493-501.

Augustin M, Ogilvie A.  Methods of outcomes measurement in nail psoriasis. Dermatology. 2010; 221 Suppl 1: 23-28.

Augustin M, Reich K, Blome C, Schäfer I, Laass A, Radtke MA. Nail psoriasis in Germany: epidemiology and burden of disease. The British Journal of Dermatology. 2010; 163(3): 580-585.

Blome C, Augustin M. Evaluation des therapeutischen Nutzens aus Patientensicht: Der Patient Benefit Index (PBI) als Beispiel für zielorientierte Präferenz- und Outcome-Messung.  Gesundheitsökonomie und Qualitätsmanagement. 2010; 15: 236-240.

Blome C, Simianer S, Purwins S, Laass A, Rustenbach SJ, Schaefer I, Radtke M, Augustin M.  Time needed for treatment is the major predictor of quality of life in psoriasis.  Dermatology. 2010; 221(2): 154-159.

Buck AK, Hermann K, Stargardt T, Dechow T, Krause B-J, Schwaiger M, Schreyögg J.  Economic Evaluation of PET and PET/CT in Oncology - Evidence and Methodological Approaches. Journal of Nuclear Medicine. 2010; 51 (3), 401-41.

Faubel R, Schäfer I, Augustin M, Bruning G. Langzeitergebnisse und Analysen von Zusammenhängen im 5 Jahr nach Varianzstripping.  Phlebologie. 2010;  39: 263-269.

Franzke N, Schäfer I, Jost K, Bloma C, Rustenbach SJ, Reich K, Reusch M, Maurer M, Augustin M.  A new Instrument for the assessment of patient-defined benefit in the treatment of allergic rhinitics. Allergy. 2010; Epub, ahead of print.

Heinrich S, Rapp K, Rissmann U, Becker C, König HH.  Cost of Falls in Old Age. A Systematic Review. Osteoporosis International. 2010; 21(6): 891-902.

Kifmann, M.  Indikationsspezifische Kosten-Nutzen-Bewertung auf Grundlage eines sozialen Gesundheitsindexes. Pharmacoeconomics - Germen Research Articles. 2010; 8(1): 5-19.

König HH, Born A, Günther O, Matschinger H, Heinrich S, Riedel-Heller SG, Angermeyer MC, Roick C. Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders. Health and Quality of Life Outcomes. 2010; 8(47).

König HH, Heider D, Lehnert T, Riedel-Heller SG, Angermeyer MC, Matschinger H, Vilagut G, Bruffaerts R, Haro JM, de Girolamo G, de Graaf R, Kovess V, Alonso J and the ESEMeD/MHEDEA 2000 investigators.  Health status of the advanced elderly in six European countries: results from a representative survey using EQ-5D and SF-12. Health and Quality of Life Outcomes. 2010;  8(143).

König HH, Heinrich S, Heider D, Deister A, Zeichner D, Birker T, Hierholzer C, Angermeyer MC, Roick C.  Das Regionale Psychiatriebudget (RPB): Ein Modell für das neue pauschalierende Entgeltsystem psychiatrischer Krankenhausleistungen? Analyse der Kosten und Effekte des RPB nach 3,5 jahren Laufzeit. Psychiatrische Praxis. 2010; 37(1): 34-42.

König HH, Luppa M, Riedel-Heller S. The costs of depression and the cost-effectiveness of treatment. Psychiat Prax. 2010; 37(5): 213-215.

Langenbruch AK, Schäfer I, Franzke N, Augustin M. Internet-supported gathering of treatment data and patient benefits in psoriasis.  Journal of the European Academy of Dermatology and Venereology. 2010;  24: 541-547.

Leicht H, Heinrich S, Rudolph A, Konnopka A, König HH.  Die Bestimmung von Krankheitskosten im Alter: Möglichkeit der Messung und Bewertung des Ressourcenverbrauchs.  Klinische Diagnostik und Evaluation. 2010; 3(3): 322-341.

Purwins S, Herberger K, Debus ES, Rustenbach SJ, Pelzer P, Rabe E, Schäfer E, Stadler R, Augustin M.  Cost-of-illness of chronic leg ulcers in Germany.  International Wound Journal. 2010; 7(2): 97-102.

Quentin W, Riedel-Heller SG, Luppa M, Rudolph A, König HH.  Cost of illness studies of dementia: A systematic review focusing on stage-dependency of costs. Acta Psychiatrica Scandinavia. 2010; 121(4): 243-259

Schäfer I, Hacker J, Rustenbach SJ, Radtke M, Franzke N, Augustin M. Concordance of the Psoriasis Area and Severity Index(PASI) and patient- reported outcomes in psoriasis treatment. European Journal of Dermatology. 2010; 20(1): 62-67.

Schmitt-Rau K, Rosenbach T, Radtke MA, Augustin M. Cost-Effectiveness of Biological Therapy in Remission Induction of Moderate to Severe Plaque Psoriasis. Dermatology. 2010;  221:  236-242.

Schreyögg J, Weller J, Stargardt T, Herrmann K, Dechow T, Glatting G, Krause BJ, Reske SN, Buck AK. Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer. Journal of Nuclear Medicine. 2010; 51(11): 1668-1675

Stark R, Reitmeier P, Leidl R, König HH.  Validity, reliability and responsiveness of the EQ-5D in inflammatory bowel disease in Germany. Inflammatory Bowel Disease. 2010; 16(1):  42-51.

Stein J, Luppa M, Brähler E, König HH, Riedel-Heller SG. The Assessment of Changes in Cognitive Functioning: Reliable Change Indices for Neuropsychological Instruments in the Elderly – A Systematic Review. Dementia and Geriatric Cognitive Disorders. 2010; 29(3): 275-286.

Augustin M, Radtke MA, Zschocke I, Blome C, Behechtnejad J, Schäfer I, Reusch M, Mielke V, Rustenbach SJ.  The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Archieves of dermatological Research. 2009; 301(8):  561-571.

Augustin M, Schaefer I, Rabini S, Lee-Seifert C, Radtke M, Rustenbach SJ.  Assessing the Value of Supportive Skin Care: Development and Validation of an Instrument for Evaluating Patient-Relevant Benefit. Dermatology. 2009; 218 (3): 255-259.

Bernert S, Fernández A, Haro JM, König HH, Alonso J, Vilagut G, Sevilla C, de Graaf R, Matschinger H, Angermeyer MC and the ESEMeD/MHEDEA 2000 investigators. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries. Value Health. 2009; 12(5):750-758. 

Berwig M, Leicht H, Gertz HJ. Critical evaluation of self-rated quality of life in mild cognitive impairment and Alzheimer's disease - Further evidence for the impact of anosognosia and global cognitive impairment. J Nutr Health Aging. 2009; 13:226-230.

Blome C, Augustin M, Siepmann D, Phan NQ, Rustenbach SJ, Ständer S.  Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool.  The British Journal of Dermatology. 2009; 161(5): 1143-1148.

Blome C, Maares J, Diepgen T, Jeffrustenbach S, Augustin M. Measurement of patient-relevant benefits in the treatment of chronic hand eczema - a novel approach. Dontact Dermatits. 2009; 61(1): 39-45.

Diepgen T, Rustenbach SJ, Augustin M.  Measurement of Patient-relevant Benefits in the Treatment of Chronic Hand Eczema - a Novel Approach. Contact Dermatitis. 2009; 61 (1): 39-45.

Ehreke L, Luppa M, Luck T, Wiese B, Weyerer S, Eifflaender-Gorfer S, Weeg D, Olbrich J, Bickel H, Bussche H van den, Bachmann C, Eisele M, Maier W, Jessen F, Wagner M, Fuchs A, Pentzek M, Angermeyer MC, König HH, Riedel-Heller SG for the AgeCoDe group. Is the Clock Drawing Test suited for screening Mild Cognitive Impairment? Results of the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe). Dement Geriatr Cogn Disord. 2009; 28(4):365-372. 

Franzke N, Debus ES, Larena-Avellaneda A, Bueltemann A, Daum H, Augustin M. Efficacy, Tolerability and Safety of Electrotherapy of Wounds with WoundEL - First Results. J Wound Technology. 2009; 6: 11.

König HH, Bernert S, Angermeyer MC, Matschinger H, Martinez M, Vilagut G, Haro JM, de Girolamo G, de Graaf R, Kovess V, Alonso J. Comparison of population health status in six European countries: results of a representative survey using the EQ-5D questionnaire. Med Care. 2009; 47(2):255-261.

König HH, Born A, Heider D, Matschinger H, Heinrich S, Riedel-Heller SG, Surall D, Angermeyer MC, Roick C. Cost-effectiveness of an optimised care model for patients with anxiety disorders in primary care. Brit J Psychiat. 2009; 195(4): 308-317.

König HH, Günther OG, Angermeyer MC, Roick C. Utility assessment in patients with mental disorders: Validity and discriminative ability of the time trade-off method. Pharmacoeconomics. 2009; 27(5): 405-419.

Konnopka A, Leichsenring F, Leibing E, König HH. Cost-of-illness studies and cost-effectiveness analyses in anxiety disorders: a systematic review. J Affect Disorders. 2009; 114(1-3): 14-31.

Marett L, Stargardt T, Mavros P, Alexander C. Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain. Diabetes Obesity and Metabolism. 2009; 11: 1138-1144.

Matschinger H, Roick C, Heider D, Riedel-Heller S, Surall D, Born A, Angermeyer MC, König HH. Zur Evaluation von cluster-randomisierten Studien durch Wachstumskurven-Modelle. Klinische Diagnostik und Evaluation. 2009; 2(4):310-326.

Porzsolt F, Schreyögg J. Die wissenschaftliche Evidenz und der Preis für Innovationen im Gesundheitssystem. Medizinische Klinik. 2009; 104(8): 622-630.

Radtke MA, Lee-Seifert C, Rustenbach SJ, Schaefer I, Augustin M. Patientennutzen und Anwendungsmerkmale der Behandlung irritierter Haut mit dexpanthenolhaltiger Salbe - Versorgungsstudie (Anwendungsbeobachtung) zur Selbstmedikation in einem Apothekennetzwerk. Hautarzt. 2009; 60 (5): 414-419.

Radtke MA, Schäfer I, Gajur A, Langenbruch A, Augustin M.  Willingness-to-pay and quality of life in patients with vitiligo.  The british Journal of Dermatology. 2009; 161(1): 134-139.

Radtke MA, Reich K, Blome C, Kopp I, Rustenbach SJ, Schäfer I, Augustin M.  Evaluation of quality of care and guideline-compliant treatment in psoriasis. Development of a new system of quality indicators.  Dermatology. 2009; 219(1): 54-58.

Schäfer I, Hansen H, Schön G, Maier W, Höfels S, Altiner A, Fuchs A, Gerlach FM, Petersen JJ, Gensichen J, Schulz S, Riedel-Heller SG, Luppa M, Weyerer S, Werle J, Bickel H, Barth K, König HH, Rudolph A, Wiese B, Prokein J, Bullinger M, von dem Knesebeck O, Eisele M, Kaduszkiewicz H, Wegscheider K, Bussche H van den.  The German MultiCare-study: Patterns of multimorbidity in primary health care - protocol of a prospective cohort study. Health Serv Res. 2009; 9:145.

Schweikert B, Hunger M, Meisinger C, König HH, Gapp O, Holle R. Quality of life several years after myocardial infarction: comparing the MONICA/KORA registry to the general population. Eur Heart J. 2009; 30(4):436-443.

Stargardt T, Alexander C, Yin D.  Treatment choice and effectiveness of adding sulphonylurea or glitazones to metformin for the treatment of type 2 diabetes mellitus.  Diabetes Obesity and Metabolism. 2009; 11: 491-497.

Stargardt, T, Gonder-Frederick L, Krobot K, Alexander C. Fear of Hypoglycaemia: Defining a Minimum Clinically Important Difference.  Health and Quality of Life Oucomes. 2009; 7(91).

Weinbrenner S, Assion H, Stargardt T, Busse R, Juckel G, Gericke C.  Antypsychotic prescription patterns for schizophrenic outpatients in Germany.  Pharmacopsychiatry. 2009;  42(2): 66-71.